This study in 12 T1D patients was compared to conventional treatment using subcutaneous NPH insulin injections (n = 14) and showed significantly higher C-peptide values in the experimental as compared to the conventional group at one-year. This evidence concerns the gene INS and type 1 diabetes mellitus.